Company record · updated August 5, 2026
GoHealth, Inc: 7 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs December 31, 2023 to December 31, 2024.
7observations
4source filings
7verified rows
2024-12-31most recent as-of date
Source rails for this company: BDC equity mark (7).
Reported by 2 filers: Blue Owl Capital Corp, Blue Owl Capital Corp II.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2024-12-31 | price per share | 13.3872 USD | Blue Owl Capital Corp | VERIFIED | Common stock: 68,125 units / fair value 912 (declared thousands) | 0001655888-26-000010 |
| 2024-12-31 | price per share | 13.4091 USD | Blue Owl Capital Corp II | VERIFIED | Common stock: 15,139 units / fair value 203 (declared thousands) | 0001655887-26-000010 |
| 2024-12-31 | price per share | 13.3872 USD | Blue Owl Capital Corp | VERIFIED | Common stock: 68,125 units / fair value 912 (declared thousands) | 0001655888-25-000007 |
| 2024-12-31 | price per share | 13.3872 USD | Blue Owl Capital Corp | VERIFIED | Common stock: 68,125 units / fair value 912 (declared thousands) | 0001655888-25-000007 |
| 2024-12-31 | price per share | 13.4091 USD | Blue Owl Capital Corp II | VERIFIED | Common stock: 15,139 units / fair value 203 (declared thousands) | 0001655887-25-000008 |
| 2023-12-31 | price per share | 13.3431 USD | Blue Owl Capital Corp | VERIFIED | Common stock: 68,125 units / fair value 909 (declared thousands) | 0001655888-25-000007 |
| 2023-12-31 | price per share | 13.343 USD | Blue Owl Capital Corp II | VERIFIED | Common Stock: 15,139 units / fair value 202 (declared thousands) | 0001655887-25-000008 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.